A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up

Long Term Results ◽

Adjuvant Tamoxifen

A randomized controlled trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with breast carcinoma of high estrogen receptor content: Long-term results at 20 years of follow-up.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.536 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 536-536

Author(s):

S. J. Johnston ◽

F. S. Kenny ◽

B. M. Syed ◽

J. F. R. Robertson ◽

S. Pinder ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Estrogen Receptor ◽

Breast Carcinoma ◽

Elderly Women ◽

Controlled Trial ◽

Long Term Results ◽

Adjuvant Tamoxifen ◽

Randomized Controlled

20-year analysis of the Nottingham EPSII – A randomised trial of primary tamoxifen versus initial mastectomy plus adjuvant tamoxifen in older women with oestrogen receptor rich early operable invasive breast carcinoma

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2012.02.005 ◽

2012 ◽

Vol 38 (5) ◽

pp. 458

Author(s):

S.J. Johnston ◽

F.S. Kenny ◽

B.M. Syed ◽

J.F.R. Robertson ◽

L. Winterbottom ◽

...

Keyword(s):

Breast Carcinoma ◽

Older Women ◽

Oestrogen Receptor ◽

Randomised Trial ◽

Adjuvant Tamoxifen

424 Long term results after conservative treatment for invasive breast carcinoma: A 20 year follow-up

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90456-3 ◽

2003 ◽

Vol 1 (5) ◽

pp. S129

Author(s):

I.Monteiro Grillo ◽

M. Jorge ◽

P.Marques Vidal ◽

M. Ortiz ◽

P. Ravasco

Keyword(s):

Breast Carcinoma ◽

Conservative Treatment ◽

Long Term Results

Faculty Opinions recommendation of Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969556.793525549 ◽

2016 ◽

Author(s):

Daniel Vorobiof

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Randomised Trial ◽

Adjuvant Tamoxifen ◽

Long Term Effects ◽

Faculty Opinions recommendation of Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969556.793480576 ◽

2013 ◽

Author(s):

Nancy Lin ◽

Ines Vaz-Luis

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Randomised Trial ◽

Adjuvant Tamoxifen ◽

Long Term Effects ◽

S-phase Fraction as an Independent Prognostic Factor in Invasive Breast Carcinoma -A Study of Long-term Follow-up

Journal of Breast Cancer ◽

10.4048/jbc.2007.10.1.36 ◽

2007 ◽

Vol 10 (1) ◽

pp. 36

Author(s):

Jin Hae Bae ◽

Jeong Won Bae ◽

Sang Uk Woo ◽

Chul Whan Kim ◽

Jae Bok Lee ◽

...

Keyword(s):

Prognostic Factor ◽

Breast Carcinoma ◽

S Phase ◽

Independent Prognostic Factor ◽

Phase Fraction ◽

Long Term Follow Up

Histological grading of invasive breast carcinoma â a simplification of existing methods in a large conservation series with long-term follow-up

Histopathology ◽

10.1111/j.1365-2559.2009.03429.x ◽

2009 ◽

Vol 55 (6) ◽

pp. 724-731 ◽

Cited By ~ 20

Author(s):

Jeremy St J Thomas ◽

Gillian R Kerr ◽

Wilma J L Jack ◽

Fiona Campbell ◽

Laura McKay ◽

...

Keyword(s):

Breast Carcinoma ◽

Histological Grading ◽

Long Term Follow Up

Faculty Opinions recommendation of Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969556.793472475 ◽

2013 ◽

Author(s):

Tommaso Simoncini

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Randomised Trial ◽

Adjuvant Tamoxifen ◽

Long Term Effects ◽

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

The Lancet ◽

10.1016/s0140-6736(12)61963-1 ◽

2013 ◽

Vol 381 (9869) ◽

pp. 805-816 ◽

Cited By ~ 1020

Author(s):

Christina Davies ◽

Hongchao Pan ◽

Jon Godwin ◽

Richard Gray ◽

Rodrigo Arriagada ◽

...

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Randomised Trial ◽

Adjuvant Tamoxifen ◽

Long Term Effects ◽

Tissue carcinoembryonic antigen and oestrogen receptor status in breast carcinoma: an immunohistochemical study of clinical outcome in a series of 252 patients with long-term follow-up

British Journal of Cancer ◽

10.1038/bjc.1998.273 ◽

1998 ◽

Vol 77 (10) ◽

pp. 1661-1668 ◽

Cited By ~ 6

Author(s):

FA Mauri ◽

O Caffo ◽

S Veronese ◽

P Verderio ◽

P Boracchi ◽

...

Keyword(s):

Breast Carcinoma ◽

Clinical Outcome ◽

Carcinoembryonic Antigen ◽

Oestrogen Receptor ◽

Immunohistochemical Study ◽

Oestrogen Receptor Status ◽

Receptor Status ◽

Long Term Follow Up